The Washington Post reported on September 30, 2026 that a leg condition called peripheral arterial disease, or PAD, is often missed in women and can increase their risk of heart attack and stroke. The paper describes the condition as overlooked in this group.
PAD involves narrowed or blocked arteries that reduce blood flow to the legs. According to the Post, the condition carries consequences beyond the legs themselves, since the same artery problems can affect the heart and brain.
Coverage of the topic has appeared across several medical and health outlets. Medscape published a piece on why detecting PAD early matters, and Drug Topics highlighted the role pharmacists play in team-based treatment of the disease. Other outlets, including zoomer.com, noted that leg pain while walking can be a sign of the condition. A separate article in hmpgloballearningnetwork.com discussed the clinical burden of PAD and the growth of peripheral vascular care based in ambulatory surgery centers.
The common thread in this reporting is that PAD is treatable and that recognizing it sooner may matter for outcomes. The Washington Post's focus on women suggests that symptoms in this group may be attributed to other causes or otherwise go unrecognized.
What to watch next: whether broader awareness efforts follow, and how clinicians and pharmacists incorporate earlier screening into routine care.
